NasdaqGS - Delayed Quote USD
GeneDx Holdings Corp. (WGS)
109.39
+3.70
+(3.50%)
At close: April 24 at 4:00:00 PM EDT
110.90
+1.51
+(1.38%)
Pre-Market: 4:43:46 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 339,606 | 22 |
| Sales | 1,394,477 | 27 |
| Net Shares Purchased (Sold) | -1,054,871 | 49 |
| Total Insider Shares Held | 3.56M | -- |
| % Net Shares Purchased (Sold) | -22.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| STUELAND KATHERINE Chief Executive Officer | Sale at price 81.16 - 97.24 per share. | Direct | 4,175,817 | Apr 9, 2025 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 83.67 - 97.26 per share. | Direct | 1,430,334 | Apr 9, 2025 |
| FEELEY KEVIN Chief Financial Officer | Conversion of Exercise of derivative security at price 32.67 per share. | Direct | 40,707 | Apr 9, 2025 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 94.58 - 95.66 per share. | Direct | 4,451,084 | Mar 26, 2025 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 94.40 - 95.66 per share. | Direct | 836,211 | Mar 26, 2025 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Mar 26, 2025 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Mar 26, 2025 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 89.44 - 96.71 per share. | Direct | 1,117,566 | Mar 17, 2025 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 90.05 - 96.71 per share. | Direct | 398,767 | Mar 17, 2025 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Mar 14, 2025 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Mar 14, 2025 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 94.73 per share. | Direct | 258,695 | Mar 10, 2025 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 94.72 per share. | Direct | 87,334 | Mar 10, 2025 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Mar 7, 2025 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Mar 7, 2025 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 103.94 per share. | Direct | 27,128 | Mar 3, 2025 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Feb 28, 2025 |
| RUCH JOSHUA Director | Conversion of Exercise of derivative security at price 7.89 per share. | Direct | 45,888 | Feb 5, 2025 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 78.48 per share. | Direct | 130,046 | Jan 29, 2025 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 78.48 per share. | Direct | 21,582 | Jan 29, 2025 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Jan 29, 2025 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Jan 29, 2025 |
| RUCH JOSHUA Director | Conversion of Exercise of derivative security at price 7.89 per share. | Direct | 23,670 | Jan 17, 2025 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 93.34 - 96.39 per share. | Direct | 4,858,119 | Jan 7, 2025 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 93.32 - 96.52 per share. | Direct | 3,331,024 | Jan 7, 2025 |
| FEELEY KEVIN Chief Financial Officer | Conversion of Exercise of derivative security at price 32.67 per share. | Direct | 366,165 | Jan 7, 2025 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 75.47 - 80.47 per share. | Direct | 1,407,686 | Jan 2, 2025 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 75.08 - 77.04 per share. | Direct | 108,737 | Jan 2, 2025 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 76.75 per share. | Direct | 805,995 | Dec 16, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 76.75 per share. | Direct | 286,139 | Dec 16, 2024 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Dec 16, 2024 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Dec 16, 2024 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 76.37 per share. | Direct | 279,598 | Dec 9, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 76.37 per share. | Direct | 86,836 | Dec 9, 2024 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Dec 9, 2024 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Dec 9, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 78.39 per share. | Direct | 20,617 | Dec 2, 2024 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Nov 29, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 69.58 - 77.40 per share. | Direct | 1,645,810 | Nov 22, 2024 |
| RYAN JASON C Director | Sale at price 68.36 - 72.26 per share. | Indirect | 3,316,880 | Nov 20, 2024 |
| RYAN JASON C Director | Stock Gift at price 0.00 per share. | Indirect | 0 | Nov 19, 2024 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 66.60 - 74.34 per share. | Direct | 3,197,684 | Nov 18, 2024 |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Beneficial Owner of more than 10% of a Class of Security | Sale at price 69.78 - 70.78 per share. | Direct | 10,393,723 | Nov 18, 2024 |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Beneficial Owner of more than 10% of a Class of Security | Sale at price 75.00 per share. | Direct | 64,935,000 | Oct 31, 2024 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 84.02 per share. | Direct | 180,979 | Oct 29, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 84.02 per share. | Direct | 23,021 | Oct 29, 2024 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Oct 29, 2024 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Oct 29, 2024 |
| RUCH JOSHUA Director | -- | Direct | -- | Oct 15, 2024 |
| RUCH JOSHUA Director | -- | Direct | -- | Oct 15, 2024 |
Related Tickers
NTRA Natera, Inc.
154.48
+3.98%
GH Guardant Health, Inc.
47.41
+3.88%
GRAL GRAIL, Inc.
37.69
+11.64%
ILMN Illumina, Inc.
77.61
+1.78%
TWST Twist Bioscience Corporation
40.17
+6.78%
DGX Quest Diagnostics Incorporated
175.87
+1.33%
OPK OPKO Health, Inc.
1.4600
-0.68%
MEDP Medpace Holdings, Inc.
302.88
+4.25%
VCYT Veracyte, Inc.
32.14
+2.15%
EXAS Exact Sciences Corporation
45.60
+3.42%